Risk Stratification by CMR After STEMI: Is it Time to Drop the Gadolinium?

JACC Cardiovasc Imaging. 2022 Mar;15(3):441-444. doi: 10.1016/j.jcmg.2021.09.010. Epub 2022 Jan 12.

Authors

Martin Reindl¹, Sebastian J Reinstadler²

Affiliations

¹ University Clinic of Internal Medicine III, Cardiology and Angiology, Medical University of Innsbruck, Innsbruck, Austria. Electronic address: [email protected].
² University Clinic of Internal Medicine III, Cardiology and Angiology, Medical University of Innsbruck, Innsbruck, Austria.

PMID: 35272809
DOI: 10.1016/j.jcmg.2021.09.010

No abstract available

Keywords: ST-segment elevation myocardial infarction; magnetic resonance imaging; risk stratification.

Publication types

Editorial
Comment

MeSH terms

Gadolinium* / adverse effects
Humans
Predictive Value of Tests
Risk Assessment
Risk Factors
ST Elevation Myocardial Infarction* / diagnostic imaging
ST Elevation Myocardial Infarction* / therapy

Substances

Gadolinium